HDAC6 — Drug Target
All drugs that target HDAC6 — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
HDAC6 inhibitor · HDAC inhibitor
Phase 2 pipeline (3)
- CG400549 · CrystalGenomics, Inc. · HDAC6 inhibitor · Oncology, Neurology
CG400549 is a selective inhibitor of histone deacetylase 6 (HDAC6) that promotes the degradation of misfolded proteins and modulates immune responses. - CEM-101 · Melinta Therapeutics, Inc. · HDAC inhibitor · Oncology
CEM-101 is a potent and selective inhibitor of the histone deacetylase 6 (HDAC6) enzyme. - GSK2269557 · GlaxoSmithKline · HDAC6 inhibitor · Oncology
GSK2269557 is a selective inhibitor of the histone deacetylase 6 (HDAC6).